Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
85.6M
-
Number of holders
-
49
-
Total 13F shares, excl. options
-
38.5M
-
Shares change
-
+23.9M
-
Total reported value, excl. options
-
$123M
-
Value change
-
+$77.8M
-
Number of buys
-
34
-
Number of sells
-
-5
-
Price
-
$3.20
Significant Holders of Larimar Therapeutics, Inc. - Common Stock, par value $0.001 per share (LRMR) as of Q3 2022
53 filings reported holding LRMR - Larimar Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q3 2022.
Larimar Therapeutics, Inc. - Common Stock, par value $0.001 per share (LRMR) has 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.5M shares
of 85.6M outstanding shares and own 44.93% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (16.9M shares), CHI Advisors LLC (3.42M shares), PERCEPTIVE ADVISORS LLC (2.86M shares), Woodline Partners LP (1.94M shares), Opaleye Management Inc. (1.66M shares), Verition Fund Management LLC (1.39M shares), MANGROVE PARTNERS (1.29M shares), GREAT POINT PARTNERS LLC (1.14M shares), VANGUARD GROUP INC (955K shares), and JANUS HENDERSON GROUP PLC (800K shares).
This table shows the top 49 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.